Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Cash from Investing Activities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Cash from Investing Activities for 5 consecutive years, with -$1000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Cash from Investing Activities rose 99.98% to -$1000.0 in Q3 2020 year-over-year; TTM through Dec 2020 was $3.6 million, a 2311.11% increase, with the full-year FY2024 number at -$36.0 million, down 76680.85% from a year prior.
  • Cash from Investing Activities was -$1000.0 for Q3 2020 at Forte Biosciences, up from -$9.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $12.7 million in Q1 2020 to a low of -$28.4 million in Q4 2017.
  • A 5-year average of -$205789.5 and a median of $756000.0 in 2018 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 266.54% in 2019, then crashed 2150.99% in 2020.
  • Forte Biosciences' Cash from Investing Activities stood at $6.8 million in 2016, then tumbled by 515.28% to -$28.4 million in 2017, then skyrocketed by 102.66% to $756000.0 in 2018, then tumbled by 111.77% to -$89000.0 in 2019, then skyrocketed by 98.88% to -$1000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Cash from Investing Activities are -$1000.0 (Q3 2020), -$9.1 million (Q2 2020), and $12.7 million (Q1 2020).